Your browser doesn't support javascript.
loading
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.
Wagh, Kshitij; Seaman, Michael S; Zingg, Marshall; Fitzsimons, Tomas; Barouch, Dan H; Burton, Dennis R; Connors, Mark; Ho, David D; Mascola, John R; Nussenzweig, Michel C; Ravetch, Jeffrey; Gautam, Rajeev; Martin, Malcolm A; Montefiori, David C; Korber, Bette.
Afiliación
  • Wagh K; Theoretical Biology & Biophysics, Los Alamos National Laboratory, Los Alamos, United States of America.
  • Seaman MS; New Mexico Consortium, Los Alamos, United States of America.
  • Zingg M; Center for Virology & Vaccine Research, Beth Israel Deaconness Medical Center, Boston, United States of America.
  • Fitzsimons T; Center for Virology & Vaccine Research, Beth Israel Deaconness Medical Center, Boston, United States of America.
  • Barouch DH; Center for Virology & Vaccine Research, Beth Israel Deaconness Medical Center, Boston, United States of America.
  • Burton DR; Center for Virology & Vaccine Research, Beth Israel Deaconness Medical Center, Boston, United States of America.
  • Connors M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, United States of America.
  • Ho DD; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda,United States of America.
  • Mascola JR; Aaron Diamond AIDS Research Center, The Rockefeller University, New York, United States of America.
  • Nussenzweig MC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Insitutes of Health, Bethesda, United States of America.
  • Ravetch J; Laboratory of Molecular Immunology, The Rockefeller University, New York, United States of America.
  • Gautam R; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, United States of America.
  • Martin MA; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, United States of America.
  • Montefiori DC; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, United States of America.
  • Korber B; Department of Surgery, Duke University Medical Center, Durham, United States of America.
PLoS Pathog ; 14(3): e1006860, 2018 03.
Article en En | MEDLINE | ID: mdl-29505593
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Infecciones por VIH / VIH-1 / Anticuerpos Biespecíficos / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Anticuerpos Neutralizantes Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Infecciones por VIH / VIH-1 / Anticuerpos Biespecíficos / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Anticuerpos Neutralizantes Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article